Table 1 Patients characteristics.
Control Group | GIH Group | p value | ||
|---|---|---|---|---|
Number | 232 | 58 | ||
Age, mean (SD) | 52.91 (19.37) | 53.34 (18.73) | 0.876 | |
Weight, median (IQR) | 75.00 [68.00–85.00] | 81.00 [69.50–89.00] | 0.04 | |
Gender (%) | Female | 4 (1.7) | 1 (1.7) | 1 |
Male | 228 (98.3) | 57 (98.3) | ||
ASA score (%) | 1 | 90 (38.8) | 25 (43.1) | 0.52 |
2 | 114 (49.1) | 25 (43.1) | ||
3 | 27 (11.6) | 7 (12.1) | ||
4 | 1 (0.4) | 1 (1.7) | ||
Anti-platelet therapy (%) | 33 (14.2) | 4 (6.9) | 0.186 | |
Anticoagulation therapy (%) | 10 (4.3) | 4 (6.9) | 0.49 | |
CHF (%) | 0 (0.0) | 2 (3.4) | 0.039 | |
Connective tissues disease | 9 (3.9) | 3 (5.2) | 0.712 | |
Chronic lung disease (COPD/asthma) | 12 (5.2) | 3 (5.2) | 1 | |
CRF (%) | 3 (1.3) | 3 (5.2) | 0.097 | |
End Stage Renal failure (%) | 1 (0.4) | 0 ( 0.0) | 1 | |
CVA (%) | 6 (2.6) | 2 (3.4) | 0.662 | |
DM (%) | 11 (4.7) | 7 (12.1) | 0.061 | |
Hematologic disease (%) | 9 (3.9) | 1 (1.7) | 0.693 | |
HTN (%) | 58 (25.0) | 13 (22.4) | 0.736 | |
IHD (%) | 24 (10.3) | 4 (6.9) | 0.619 | |
Hemiplegia (polio, etc.) | 2 (0.9) | 1 (1.7) | 0.489 | |
PVD (%) | 2 (0.9) | 1 (1.7) | 0.489 | |
S/p Chemotherapy treatment (%) | 8 (3.4) | 2 (3.4) | 1 | |
Smoker (%) | 69 (29.7) | 16 (27.6) | 0.872 | |
VHD (%) | 5 (2.2) | 1 (1.7) | 1 | |
Hernia side (%) | Left | 103 (44.4) | 35 (60.3) | 0.039 |
Right | 129 (55.6) | 23 ( 39.7) | ||
Hernia duration (%) | weeks | 5 (2.2) | 1 (1.7) | < 0.001 |
months | 146 (63.5) | 4 (6.9) | ||
years | 79 (34.3) | 53 (91.4) | ||
Previous ipsilateral groin surgery (%) | 24 (10.3) | 15 (25.9) | 0.004 | |
Palpable testis on physical exam (%) | 228 (98.3) | 34 (58.6) | < 0.001 | |
Hernia contains bowel on physical examination (%) | 36 (15.5) | 40 (69.0) | < 0.001 |